PLx Pharma stock rises today by over 18% after announcing to launch in more than 8 thousand Walgreens Stores in US. The stock was trading at $16.70 on July 19. At the start of the trading session today on July 20 the stock has skyrocketed by 18% to the price equaling $20.03.
PLx Pharma is a specialty pharmaceutical company that uses its patented and clinical-validated PLxGuardTM platform to provide better and safer products. Its lead products, VAZALORE ®️ 325 and 81 mg, are the first and only FDA-approved liquid-filled aspirin tablets. placeholders have been placed on shelves for all three VAZALORE SKUs.
VAZALORE will be available in over 8,000 Walgreens stores across the country. As part of its commercial launch, the company has partnered with Walgreens to carry all three of its SKUs. VAZALOORE is a liquid-filled capsule that’s indicated for the treatment of vascular disease and diabetic individuals with high blood pressure. It has been shown to provide faster, reliable and predictable blood platelet inhibition.